- ISIN
- US03675P1021
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Dec 13, 2024
Highlights
- Market Cap
- $288.42M
- Enterprise Value
- $10.26M
- EPS (TTM)
- -$5.99
- Total Revenue (TTM)
- $1.85M
- Gross Profit (TTM)
- $1.38M
- EBITDA (TTM)
- -$69.11M
- Year Range
- $3.09 - $11.06
- Target Price
- $15.00
- ROA (TTM)
- -31.96%
- ROE (TTM)
- -33.83%
- Avg. Volume (1M)
- 1M
- Avg. Volume Value (1M)
- $9.78M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
AVR Performance Chart
Anteris Technologies Global Corp (AVR) is up 57.1% since the beginning of the year. At $8 per share, AVR is trading 29.1% below its 52-week high of $11.
Loading charts...
Compare this symbol against anything
Returns By Period
Anteris Technologies Global Corp (AVR) has returned 57.11% so far this year and 155.37% over the past 12 months.
Anteris Technologies Global Corp
- 1D
- -4.85%
- 1M
- -23.44%
- 6M
- 31.32%
- YTD
- 57.11%
- 1Y
- 155.37%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 17.84%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
AVR Monthly Returns History
Based on dividend-adjusted daily data since Dec 13, 2024, AVR's average daily return is +0.22%, while the average monthly return is +3.67%. At this rate, an investment would double in approximately 1.6 years.
Historically, 55% of months were positive and 45% were negative. The best month was May 2026 with a return of +40.2%, while the worst month was Mar 2025 at -48.0%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 3 months.
On a daily basis, AVR closed higher 45% of trading days. The best single day was May 27, 2025 with a return of +31.9%, while the worst single day was Apr 11, 2025 at -16.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 19.64% | 9.05% | -14.75% | 10.81% | 40.16% | 14.27% | -20.41% | 57.11% | |||||
| 2025 | 11.11% | 12.90% | -48.00% | 35.99% | -14.34% | -10.61% | -15.30% | 25.23% | 11.94% | -0.22% | -8.69% | 21.71% | -10.57% |
| 2024 | -7.00% | -7.00% |
Benchmark Metrics
Anteris Technologies Global Corp has an annualized alpha of 36.92%, beta of 1.65, and R2 of 0.10 versus S&P 500 Index. Calculated based on daily prices since December 13, 2024.
- This stock captured 147.03% of S&P 500 Index gains and 139.11% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.10 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 36.92%
- Beta
- 1.65
- R²
- 0.10
- Upside Capture
- 147.03%
- Downside Capture
- 139.11%
Return for Risk
Risk / Return Rank
AVR ranks 87 for risk / return — above 87% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Anteris Technologies Global Corp (AVR) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVR | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.50 | ||
| Sortino ratioReturn per unit of downside risk | +0.74 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.25 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 3.10 | 2.00 | +1.10 |
| Martin ratioReturn relative to average drawdown | 7.98 | 8.49 | -0.52 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Anteris Technologies Global Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Anteris Technologies Global Corp was 71.46%, occurring on Apr 11, 2025. Recovery took 278 trading sessions.
The current Anteris Technologies Global Corp drawdown is 25.83%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-71.46%Apr 2025 | 1mo 21d | 1y 1mo | 1y 3moFeb 2025 - May 2026 | 2025 selloff2025 |
-25.83%Jul 2026 | 24d | — | 27dJul 2026 - now | — |
-10.40%May 2026 | 3d | 6d | 9dMay 2026 - Jun 2026 | — |
-8.50%Dec 2024 | 13d | 15d | 28dDec 2024 - Jan 2025 | — |
-6.83%Jun 2026 | 1d | 10d | 11dJun 2026 - Jul 2026 | — |
Drawdown Indicators
| AVR | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.46% | -56.78% | -14.68% |
Max Drawdown (1Y)Largest decline over 1 year | -46.77% | -9.10% | -37.67% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -25.83% | -1.58% | -24.25% |
Average DrawdownAverage peak-to-trough decline | -34.71% | -10.70% | -24.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.16% | 2.14% | +16.02% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Anteris Technologies Global Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Anteris Technologies Global Corp is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AVR relative to other companies in the Medical Instruments & Supplies industry. Currently, AVR has a P/S ratio of 66.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with AVR
Add Anteris Technologies Global Corp to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with AVR